"10.1371_journal.pone.0074062","plos one","2013-09-09T00:00:00Z","Angela Rizk-Jackson; Philip Insel; Ronald Petersen; Paul Aisen; Clifford Jack; Michael Weiner","Center for Imaging of Neurodegenerative Disease, Veterans Administration Medical Center, San Francisco, California, United States of America; Mayo Alzheimer's Disease Research Center, Rochester, Minnesota, United States of America; Alzheimer's Disease Cooperative Study, University of California, San Diego, La Jolla, California, United States of America","Conceived and designed the experiments: RP PA CJ MW. Analyzed the data: ARJ PI. Wrote the paper: ARJ PI.","The authors have the following interests. Dr. Weiner has served on scientific advisory boards for Eli Lilly, Araclon, Biogen Idec and Pfizer; has served as a consultant to Astra Zeneca, Araclon, Medivation/Pfizer, Ipsen, TauRx Therapeutics Ltd, Bayer Healthcare, Biogen Idec, Exonhit Therapeutics, Servier, Synarc, Janssen, and KLJ Associates; has received funding for travel from NeuroVigil Inc, Siemens, AstraZeneca, Eli Lilly, Ipsen, Novartis, and Travel eDreams, Inc; has received honoraria from NeuroVigil, Inc, has received research support from Merck and Avid; and has stock options for Synarc and Elan. This does not alter their adherence to all the PLOS ONE policies on sharing data and materials.",NA,NA,NA,"2013","09","Angela Rizk-Jackson","ARJ",6,TRUE,4,NA,2,2,TRUE,TRUE,FALSE,0,NA,FALSE
